Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q3 FY2011 Earnings Presentation
23 slides from Apollo Hospitals Enterprise's earnings presentation, Mar 13, 2011
Slide 1: Apollo Hospitals Enterprise Limited Q3 FY 2011 Earnings Update
Apollo Hospitals Enterprise Limited Q3 FY 2011 Earnings Update
Slide 2: Safe Harbour
Safe Harbour Numbers mentioned in this Presentation in respect of information provided on hospital operating parameters and other operating metrics have been compiled by the management and are being provided only by way of additional information. These are not to be construed as being provided under
Slide 3: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 3
Slide 4: Q3 Highlights (1/2)
Q3 Highlights – (1/2) • YTD Dec FY 11 Consolidated revenues - Rs.18,997 million (up 27.4% yoy) • YTD Dec FY 11 Consolidated EBITDA - Rs. 3,152 million (up 32.8% yoy) Performance • Consolidated EBITDA margin expanded 68 bps to 16.6%. • Retail pharmacies continued to demonstrate improvement in operati
Slide 5: Q3 Highlights (2/2)
Q3 Highlights – (2/2) Launched the Apollo Cosmetic Clinics during the quarter. These state-of-the-art clinics will Major • be centers of excellence offering comprehensive treatments for a range of cosmetic Initiatives & enhancements and will enable AHEL to offer its expertise to the fast growing mar
Slide 6: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 6
Slide 7: Consolidated Financial Performance
Consolidated Financial Performance * [Excluding Apollo Munich Health Insurance] ` Mio YTD Dec YTD Dec Q3 FY'10 Q3 FY'11 yoy (%) FY'10 FY'11 yoy (%) Income from Operations 5,015 6,136 22.3% 14,105 17,935 27.1% Add: Share of JVs 234 297 26.7% 716 922 28.7% Total Revenues 5,249 6,432 22.5% 14,821 18,85
Slide 8: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 8
Slide 9: Standalone Financial Performance (1/2)
Standalone Financial Performance – (1/2) ` Mio YTD Dec YTD Dec Q3 FY'10 Q3 FY'11 yoy (%) FY'10 FY'11 yoy (%) Revenue 4,809 6,009 13,429 17,106 • YTD Dec FY11 Total Income 4,809 6,009 25.0% 13,429 17,106 27.4% revenue growth at 27.4% Operative Expenses (2,634) (3,328) 26.3% (7,334) (9,362) 27.6% • YT
Slide 10: Standalone Segment-wise Performance (2/2)
Standalone Segment-wise Performance – (2/2) ` Mio YTD Dec YTD Dec Q3 FY'10 Q3 FY'11 yoy (%) FY'10 FY'11 yoy (%) Revenues from each segment • 24.2% yoy growth Heathcare Services * 3,482 4,277 22.8% 9,917 12,317 24.2% in Healthcare Stand-alone Pharmacy 1,329 1,734 30.5% 3,514 4,793 36.4% Services segm
Slide 11: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 11
Slide 12: Operational Performance - Hospitals
Operational Performance - Hospitals ` Mio AHEL Standalone Hospitals AHEL Standalone Hospitals Chennai Cluster Hyderabad Cluster Others* SIGNIFICANT SUBS / JVs** YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec YTD Dec FY'10 FY'11 yoy % FY'10 FY'11 yoy % FY'10 FY'11 yoy % FY'10
Slide 13: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 13
Slide 14: Operational Performance – Retail Pharmacy
Operational Performance – Retail Pharmacy ` Mio • Retail Pharmacy YTD Dec YTD Dec operations continuing Q3 FY 10 Q3 FY 11 yoy% yoy% Particulars FY 10 FY 11 to grow rapidly, with a steady path to No of Stores 321 315 321 315 profitability Total Area Sq ft/store 280 281 280 281 Upto • LFL revenue per
Slide 15: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 15
Slide 16: Key Hospital Expansion Plan & Update on Execution
Key Hospital Expansion Plan & Update on Execution Upto Description Investment Details Dec'10 Est. Date of Operational beds of Project Total AHEL AHEL Completion FY 11 FY 12 FY 13 FY 14 Cost Share Invested Est. Est. Est. Est. Rs. Millions Own Projects Hyderabad - International Block Expansion 1,225 1
Slide 17: Contents
Contents • Q3 Highlights • Consolidated Financial Performance • Standalone Financial Performance • Operational Performance - Hospitals • Operational Performance - Retail Pharmacy • Update on Projects • Update on non-hospital JVs, Associates 17
Slide 18: Apollo Health Street Update
Apollo Health Street Update* ` Mio YTD Dec YTD Dec Q3 FY '10 Q3 FY '11 yoy (%) FY' 10 FY' 11 yoy (%) Revenues 1,136 1,056 -7% 3,477 3,253 -6% Other Income 39 (5) 43 17 -60% Total Income 1,175 1,051 -11% 3,520 3,270 -7.1% Operative Expenses 316 244 -23% 1,050 839 -20.1% Employee Expenses 604 646 7% 1
Slide 19: Apollo Munich Health Insurance Company Update
Apollo Munich Health Insurance Company Update * ` Mio YTD Dec YTD Dec Q3 FY '10 Q3 FY '11 yoy (%) FY' 10 FY' 11 yoy (%) Gross Written Premium 310 528 70% 799 1,402 75% Earned Premium 197 366 86% 475 963 103% Other Income (incl. Interest Income) 27 37 37% 74 104 41% Total Income 224 403 80% 548 1,067
Slide 20: Q&A
Q&A 20
Slide 21: Consolidated Financial Performance (Including Apollo Munich)
Consolidated Financial Performance * [Including Apollo Munich Health Insurance] ` Mio YTD Dec YTD Dec Q3 FY'10 Q3 FY'11 yoy (%) FY'10 FY'11 yoy (%) Income from Operations 5,015 6,136 22.3% 14,105 17,935 27.1% Add: Share of JVs 262 326 24.7% 808 1,063 31.6% Total Revenues 5,277 6,462 22.5% 14,913 18,
Slide 22: Appendix: Basis of Consolidation
Appendix: Basis of Consolidation AHEL Location Description Ownership AHEL Standalone Chennai Main Chennai Hospital 100% ASH - Chennai Chennai Hospital 100% Tondiarpet - Chennai Chennai Hospital 100% FirstMed - Chennai Chennai Hospital 100% Apollo Children's Hospital Chennai Hospital 100% Madurai Mad
Slide 23: Hospitals – Understanding Key Operating Metrics
Hospitals – Understanding Key Operating Metrics Description Formula / Calculation Key Driver • Number of operating • - • Project execution Operating Beds beds • Capital Expenditure x Outpatient • In-patient Bed Days • In-patient Bed Days • Brand Occupancy Visits Billed • Doctor reputation • Quality
Apollo Hospitals Enterprise — Q3 FY2011 Earnings Presentation on 6ix